Pain Therapeutics endures yet another FDA slapdown on Remoxy — time to call it quits?

The pain just won’t stop for Pain Therapeutics. A panel of outside experts at the FDA today slapped down their latest attempt to get Remoxy ER over the finish line and into the market.